The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, R. J.
Right arrow Articles by Lechler, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, R. J.
Right arrow Articles by Lechler, R. I.
The Journal of Immunology, 2001, 167: 7199-7206.
Copyright © 2001 by The American Association of Immunologists

Loss of Direct and Maintenance of Indirect Alloresponses in Renal Allograft Recipients: Implications for the Pathogenesis of Chronic Allograft Nephropathy1

Richard J. Baker2,*, Maria P. Hernandez-Fuentes2,*, Paul A. Brookes*, Afzal N. Chaudhry{dagger}, H. Terry Cook{ddagger} and Robert I. Lechler3,*

Departments of * Immunology, {dagger} Renal Medicine, and {ddagger} Histopathology, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom

Chronic allograft nephropathy (CAN) is the principal cause of late renal allograft failure. This complex process is multifactorial in origin, and there is good evidence for immune-mediated effects. The immune contribution to this process is directed by CD4+ T cells, which can be activated by either direct or indirect pathways of allorecognition. For the first time, these pathways have been simultaneously compared in a cohort of 22 longstanding renal allograft recipients (13 with good function and nine with CAN). CD4+ T cells from all patients reveal donor-specific hyporesponsiveness by the direct pathway according to proliferation or the secretion of the cytokines IL-2, IL-5, and IFN-{gamma}. Donor-specific cytotoxic T cell responses were also attenuated. In contrast, the frequencies of indirectly alloreactive cells were maintained, patients with CAN having significantly higher frequencies of CD4+ T cells indirectly activated by allogeneic peptides when compared with controls with good allograft function. An extensive search for alloantibodies has revealed significant titers in only a minority of patients, both with and without CAN. In summary, this study demonstrates widespread donor-specific hyporesponsiveness in directly activated CD4+ T cells derived from longstanding recipients of renal allografts, whether they have CAN or not. However, patients with CAN have significantly higher frequencies of CD4+ T cells activated by donor Ags in an indirect manner, a phenomenon resembling split tolerance. These findings provide an insight into the pathogenesis of CAN and also have implications for the development of a clinical tolerance assay.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
T. Ueno, K. Tanaka, M. Jurewicz, T. Murayama, I. Guleria, P. Fiorina, J. C. Paez, A. Augello, A. Vergani, M. Wong, et al.
Divergent Role of Donor Dendritic Cells in Rejection versus Tolerance of Allografts
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 535 - 544.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J Galliford and D S Game
Modern renal transplantation: present challenges and future prospects
Postgrad. Med. J., February 1, 2009; 85(1000): 91 - 101.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
O. Bestard, P. Nickel, J. M. Cruzado, C. Schoenemann, O. Boenisch, A. Sefrin, J. M. Grinyo, H.-D. Volk, and P. Reinke
Circulating Alloreactive T Cells Correlate with Graft Function in Longstanding Renal Transplant Recipients
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1419 - 1429.
[Full Text] [PDF]


Home page
CJASNHome page
E. Akalin, R. Dinavahi, S. Dikman, G. de Boccardo, R. Friedlander, B. Schroppel, V. Sehgal, J. S. Bromberg, P. Heeger, and B. Murphy
Transplant Glomerulopathy May Occur in the Absence of Donor-Specific Antibody and C4d Staining
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1261 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Mahesh, H.-S. Leong, A. McCormack, P. Sarathchandra, A. Holder, and M. L. Rose
Autoantibodies to Vimentin Cause Accelerated Rejection of Cardiac Allografts
Am. J. Pathol., April 1, 2007; 170(4): 1415 - 1427.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Iacomini and M. H. Sayegh
Measuring T Cell Alloreactivity to Predict Kidney Transplant Outcomes: Are We There Yet?
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 328 - 330.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. S. Neto, A. Nakao, H. Toyokawa, M. A. Nalesnik, A. J. Romanosky, K. Kimizuka, T. Kaizu, N. Hashimoto, O. Azhipa, D. B. Stolz, et al.
Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F324 - F334.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. Mirenda, D. Golshayan, J. Read, I. Berton, A. N. Warrens, A. Dorling, and R. I. Lechler
Achieving Permanent Survival of Islet Xenografts by Independent Manipulation of Direct and Indirect T-Cell Responses
Diabetes, April 1, 2005; 54(4): 1048 - 1055.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. H. Sayegh and C. B. Carpenter
Transplantation 50 Years Later -- Progress, Challenges, and Promises
N. Engl. J. Med., December 23, 2004; 351(26): 2761 - 2766.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. D. Poggio, M. Clemente, J. Riley, M. Roddy, N. S. Greenspan, C. Dejelo, N. Najafian, M. H. Sayegh, D. E. Hricik, and P. S. Heeger
Alloreactivity in Renal Transplant Recipients with and without Chronic Allograft Nephropathy
J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1952 - 1960.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Chalasani, Q. Li, B. T. Konieczny, L. Smith-Diggs, B. Wrobel, Z. Dai, D. L. Perkins, F. K. Baddoura, and F. G. Lakkis
The Allograft Defines the Type of Rejection (Acute versus Chronic) in the Face of an Established Effector Immune Response
J. Immunol., June 15, 2004; 172(12): 7813 - 7820.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. Mirenda, I. Berton, J. Read, T. Cook, J. Smith, A. Dorling, and R. I. Lechler
Modified Dendritic Cells Coexpressing Self and Allogeneic Major Histocompatability Complex Molecules: An Efficient Way to Induce Indirect Pathway Regulation
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 987 - 997.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Chen, Y. Demir, A. Valujskikh, and P. S. Heeger
Antigen Location Contributes to the Pathological Features of a Transplanted Heart Graft
Am. J. Pathol., April 1, 2004; 164(4): 1407 - 1415.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Richards, S. L. Dalheimer, B. D. Ehst, T. L. Vanasek, M. K. Jenkins, M. I. Hertz, and D. L. Mueller
Indirect Minor Histocompatibility Antigen Presentation by Allograft Recipient Cells in the Draining Lymph Node Leads to the Activation and Clonal Expansion of CD4+ T Cells That Cause Obliterative Airways Disease
J. Immunol., March 15, 2004; 172(6): 3469 - 3479.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. D. Salama, N. Najafian, M. R. Clarkson, W. E. Harmon, and M. H. Sayegh
Regulatory CD25+ T Cells in Human Kidney Transplant Recipients
J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1643 - 1651.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. S. Game, M. P. Hernandez-Fuentes, A. N. Chaudhry, and R. I. Lechler
CD4+CD25+ Regulatory T Cells Do Not Significantly Contribute to Direct Pathway Hyporesponsiveness in Stable Renal Transplant Patients
J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1652 - 1661.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. F. Ng, M. Hernandez-Fuentes, R. Baker, A. Chaudhry, and R. I. Lechler
Reversibility with Interleukin-2 Suggests that T Cell Anergy Contributes to Donor-Specific Hyporesponsiveness in Renal Transplant Patients
J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2983 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Regele, G. A. Bohmig, A. Habicht, D. Gollowitzer, M. Schillinger, S. Rockenschaub, B. Watschinger, D. Kerjaschki, and M. Exner
Capillary Deposition of Complement Split Product C4d in Renal Allografts is Associated with Basement Membrane Injury in Peritubular and Glomerular Capillaries: A Contribution of Humoral Immunity to Chronic Allograft Rejection
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2371 - 2380.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Watschinger and M. Pascual
Capillary C4d Deposition as a Marker of Humoral Immunity in Renal Allograft Rejection
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2420 - 2423.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.